相关临床试验
38
8 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1818
进行中（未招募）
2
5.3%
已完成
11
28.9%
Enrolling By Invitation
3
7.9%
尚未招募
3
7.9%
招募中
14
36.8%
Unknown
5
13.2%
暂无批准数据
- Researchers have demonstrated for the first time that adult human hearts produce new muscle cells after a heart attack, a phenomenon previously documented only in mice. - The finding, published in Circulation Research, relied on a world-first model using heart tissue collected from living patients during bypass surgery. - Cardiovascular disease remains the leading cause of death worldwide, and a heart attack can destroy as many as one third of the cells in the human heart. - The regenerative response is too weak to prevent heart failure, but researchers hope to amplify it to reverse the condition, for which transplant is the only cure.
- A 2-day oatmeal diet (300 g/day) reduced LDL cholesterol by 10% in metabolic syndrome patients, with effects persisting at 6 weeks, according to a University of Bonn trial published in Nature Communications. - Daily avocado consumption over 6 months was associated with lower dietary glycemic load compared to minimal intake, per a secondary analysis in Current Developments in Nutrition. - Peppermint oil (100 μL/day) lowered systolic blood pressure by an average of 8.5 mmHg in adults with pre-hypertension or stage 1 hypertension in a 20-day PLOS One study. - Experts caution that while findings are promising, longer-term and larger studies are needed to confirm sustainability and real-world applicability of these interventions.
- The PRIMA subretinal implant demonstrated clinically meaningful vision improvement in 81% of patients with geographic atrophy secondary to age-related macular degeneration at 12 months. - Patients achieved an average improvement of 23 letters on visual acuity tests, with the best performers gaining 59 letters, enabling reading and writing tasks. - The wireless 2×2 mm device bypasses damaged photoreceptors by stimulating bipolar cells through 378 photovoltaic pixels activated by near-infrared light. - Safety profile showed 26 serious adverse events in 19 patients, all related to the surgical procedure rather than the implant itself, with 95% resolving within two months.
- Pharmaceutical and biotech companies across Europe and North America have made significant board appointments, bringing industry veterans and scientific experts to strengthen their leadership teams. - Notable appointments include former CDC Director Dr. Julie Louise Gerberding joining ARTIDIS and former Roche neuroscience head Dr. Paulo Fontoura taking on dual advisory roles. - Companies ranging from clinical-stage biotechs to established pharmaceutical firms are adding expertise in areas including oncology, neuroscience, infectious diseases, and antimicrobial resistance.
